Stock Analysts

Rockwell Collins Hits 52-Week High on the ARINC Acquisition

On Dec 24, 2014, shares of Rockwell Collins Inc. ( COL ) soared to a new 52-week high of $86.57, finally ending the trading session a tad lower at $86.16. This defense prime, with a market cap of around $11.45 billion, has seen its shares surge roughly 16.37% in the last 52 weeks, outperforming the 13.02% gain of the S&P 500 over the same period. […]

Stock Analysts

Federal Realty Eyes Premium Markets: Should you Hold?

On Dec 23, 2014, we issued an updated research report on Federal Realty Investment Trust ( FRT ). The Rockville, MD-based retail real estate investment trust (“REIT”) is continuing with its strategy of expanding into premier markets. The company’s decent balance sheet position and ample liquidity have helped it capitalize on expansion opportunities […]

Stock Analysts

Mack-Cali & New Jersey City University Ink 20-Year Lease

Ushering positive news for its New Jersey platform, Mack-Cali Realty Corporation ( CLI ) announced the signing of a new 20-year lease deal with the New Jersey City University for a 68,348-square-feet space at Harborside Plaza 2 in Jersey City, NJ. On Dec 23, 2014, the company revealed that this building, located on the Jersey City Waterfront, is currently undergoing major renovations. […]

Stock Analysts

Roche’ (RHHBY) Blood Cancer Drug Gazyva’s Label Updated

Roche ( RHHBY ) announced that the FDA has approved a supplemental biologics license application (sBLA) for its blood cancer drug, Gazyva in combination with chlorambucil chemotherapy in patients suffering from treatment-naïve chronic lymphocytic leukemia (CLL). The approval of the sBLA adds positive data from stage II of the CLL11 study to its label, wherein it was observed that Gazyva plus chlorambucil showed significant improvement across multiple clinical endpoints when compared head-to-head with Rituxan plus chlorambucil. […]

Stock Analysts

Southwestern Energy Buys More Marcellus, Utica Assets

Houston-based Southwestern Energy Company ’s ( SWN ) share price surprised with a fall of 1.6% following the news that the company has inked a purchase and sale agreement for an undivided 20% of Statoil ASA's ( STO ) ownership in oil and gas assets in West Virginia and southwest Pennsylvania. Subject to adjustments, the purchase price has been fixed at $394 million. This announcement comes a day after the company closed a nearly $4.98 billion deal to acquire Oklahoma City-based Chesapeake Energy Corp.’s ( CHK ) interest in 413,000 acres in the Marcellus and Utica shale plays. […]

Stock Analysts

Haemonetics Q2 Results Let Down by Poor Disposables Show

On Dec 19, 2014, we issued an updated research report on blood management solutions provider, Haemonetics Corporation ( HAE ). We are disappointed with Haemonetics’ second-quarter fiscal 2015 performance. However, a factor that lends optimism is the company’s expectation of profitable growth in plasma, Thrombelastograph Hemostasis Analyzer (TEG) and emerging markets through the rest of fiscal 2015. […]

Stock Analysts

Genuine Parts Hits 52-Week High on Rise in Miles Driven

On Dec 24, 2014, shares of Genuine Parts Company ( GPC ) reached a 52-week high of $108.11, before eventually closing at $107.62. The closing price represents a year-to-date return of 34.8%. Share Price Drivers Increase in the miles driven by Americans due to declining gas price is giving a boost to auto parts retailers and suppliers including Genuine Parts. […]